Also trades as: AZN.L (LSE) · $vol 541M · AZN.ST (STO) · $vol 91M · AZNCF (OTC) · $vol 31M · ZEG.DE (XETRA) · $vol 1M

$170.08

-1.98 (-1.15%)

After Hours: $170.75 (+0.67, +0.39%)

Weekly Expected Move ±3.9%

$158 $165 $171 $178 $185

NYSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 68 · $266.8B mcap · 1.54B float · 0.206% daily turnover · Short 59% of daily vol

Credit Risk of going bust: lower than 80% of companies Debt: 10.8% of company value Bonds: $298.6M held by 249 funds, 47 bp over Treasuries → details ▾

If the stock fell to about $1.56 (down 99.1%), AstraZeneca PLC would be worth roughly what it owes.
Total debt $32.20B against a stock market value of $266.84B.
Distance to default 9.60 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $18.05B (short-term plus half of long-term), stock volatility 30.6%; Altman Z'' 1.79. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Low

$211

Avg Target

$211

High

Based on 2 analyst ratings (12 mo)

Analyst Recommendations

Strong Buy: 1Buy: 19Hold: 15Sell: 6Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$211.00

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2025-12-10	HSBC	—	Initiated	$108	—	-39.9%	$179.64
2025-12-03	Morgan Stanley	—	Initiated	$103	—	-42.9%	$180.34
2025-07-09	Berenberg Bank	Luisa Hector	Initiated	$97	—	-31.5%	$141.64
2024-11-13	BMO Capital	Etzer Darout	$89	$88	-1	-45.8%	$162.38
2024-09-11	BMO Capital	Etzer Darout	$82	$89	+7	-44.3%	$159.88
2024-05-30	Argus Research	John Eade	Initiated	$85	—	-44.7%	$153.68
2024-05-28	BMO Capital	Etzer Darout	$82	$82	0	-46.6%	$153.48
2023-07-12	Leerink Partners	Andrew Berens	$78	$79	+1	-39.1%	$129.72
2023-01-05	BMO Capital	—	Initiated	$82	—	-41.0%	$139.00
2022-11-10	Leerink Partners	—	$75	$78	+3	-40.1%	$130.18
2022-05-04	Leerink Partners	—	Initiated	$75	—	-44.2%	$134.34

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AZN receives an overall rating of B+. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).

Rating Change History

Date	From	To
2026-10-26	A-	B+
2026-10-22	B+	A-
2026-10-16	A-	B+
2026-10-14	B+	A-
2026-08-14	A-	B+
2026-08-05	A	A-
2026-07-30	A-	A
2026-07-10	B+	A-
2026-05-04	A-	B+
2026-05-01	C	A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 71 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AZN scores highest in Momentum (90/100) and lowest in Value (45/100). An overall grade of A+ places AZN among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

3.75

Safe Zone

Piotroski F-Score

9/9

✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓

Beneish M-Score

-2.52

Unlikely Manipulator

Ohlson O-Score

-8.81

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA-

Score: 82.0/100

Trend: Improving

Earnings Quality

100/100

OCF/NI: 1.32x

Accruals: -2.9%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AZN scores 3.75, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AZN scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AZN's score of -2.52 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AZN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AZN receives an estimated rating of AA- (score: 82.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). AZN's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

25.45x

PEG

1.09x

P/S

4.32x

P/B

5.24x

P/FCF

30.05x

P/OCF

21.28x

EV/EBITDA

15.53x

EV/Revenue

5.23x

EV/EBIT

22.42x

EV/FCF

32.83x

Earnings Yield

3.55%

FCF Yield

3.33%

Shareholder Yield

1.75%

Graham Number

$69.65

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 25.4x earnings, AZN commands a growth premium. Graham's intrinsic value formula yields $69.65 per share, 147% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.830

NI / EBT

Interest Burden

0.879

EBT / EBIT

EBIT Margin

0.233

EBIT / Rev

Asset Turnover

0.538

Rev / Assets

Equity Multiplier

2.402

Assets / Equity

ROE

22.0%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AZN's ROE of 22.0% is driven by Asset Turnover (0.538), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$257.80

Price/Value

0.73x

Margin of Safety

26.93%

Premium

-26.93%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with AZN's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. AZN actually compounded EPS at 50.2% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. AZN trades at a -27% premium to its adjusted intrinsic value of $257.80, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 25.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$170.02

Median 1Y

$178.42

5th Pctile

$101.14

95th Pctile

$314.54

Ann. Volatility

35.0%

25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

96,100

+1.9% YoY

Revenue / Employee

$611,228

Rev: $58,739,000,000

Profit / Employee

$106,712

NI: $10,255,000,000

SGA / Employee

$213,444

Avg labor cost proxy

R&D / Employee

$148,096

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	5.7%	0.4%	-4.2%	-4.9%	5.4%	8.6%	13.0%	16.8%	16.3%	15.6%	17.3%	16.7%	16.7%	17.6%	19.8%	19.7%	21.7%	22.9%	23.5%	22.0%	22.00%
ROA	1.7%	0.1%	-1.3%	-1.5%	2.0%	3.3%	4.8%	6.4%	6.2%	6.0%	6.4%	6.4%	6.5%	6.9%	7.5%	7.7%	8.6%	9.4%	9.4%	9.2%	9.16%
ROIC	4.2%	1.3%	0.1%	-0.7%	7.5%	8.3%	10.0%	12.2%	11.6%	11.4%	11.7%	11.4%	11.2%	12.4%	13.1%	13.3%	15.0%	15.6%	15.7%	15.0%	14.98%
ROCE	3.3%	1.2%	-0.0%	-0.7%	3.4%	5.5%	7.8%	10.7%	12.3%	12.1%	12.4%	12.5%	12.3%	13.7%	14.2%	14.8%	16.3%	16.9%	18.0%	17.0%	17.01%
Gross Margin	61.9%	61.5%	69.2%	72.2%	72.8%	74.1%	82.5%	82.8%	81.8%	80.8%	82.5%	83.1%	77.3%	81.7%	83.5%	82.9%	81.6%	79.9%	82.5%	83.6%	83.60%
Operating Margin	-17.0%	-2.4%	7.7%	5.0%	11.3%	9.8%	23.4%	21.5%	17.0%	10.3%	24.6%	21.2%	15.5%	13.7%	27.0%	24.3%	23.6%	19.2%	27.8%	20.6%	20.57%
Net Margin	-16.7%	-2.9%	3.4%	3.3%	14.9%	8.0%	16.6%	15.9%	12.0%	8.0%	17.2%	14.9%	10.5%	10.1%	21.5%	16.9%	16.7%	15.0%	20.1%	16.3%	16.30%
EBITDA Margin	11.4%	15.6%	19.3%	17.8%	23.6%	21.2%	38.0%	33.2%	28.9%	22.2%	35.2%	31.8%	30.2%	18.9%	37.1%	34.3%	34.4%	29.7%	37.1%	33.6%	33.56%
FCF Margin	13.3%	10.2%	12.6%	12.1%	13.5%	16.3%	13.8%	14.7%	15.5%	14.3%	12.2%	14.2%	13.2%	13.5%	17.6%	15.4%	19.2%	18.0%	15.1%	15.9%	15.94%
OCF Margin	19.3%	15.9%	17.5%	17.3%	19.6%	22.1%	22.1%	22.9%	23.0%	22.6%	20.4%	22.5%	22.1%	21.9%	23.8%	23.7%	26.0%	25.0%	23.7%	22.5%	22.50%
ROE 3Y Avg	snapshot only																				18.55%
ROE 5Y Avg	snapshot only																				13.73%
ROA 3Y Avg	snapshot only																				7.53%
ROIC 3Y Avg	snapshot only																				11.03%
ROIC Economic	snapshot only																				14.29%
Cash ROA	snapshot only																				11.94%
Cash ROIC	snapshot only																				17.83%
CROIC	snapshot only																				12.62%
NOPAT Margin	snapshot only																				18.91%
Pretax Margin	snapshot only																				20.51%
R&D / Revenue	snapshot only																				24.56%
SGA / Revenue	snapshot only																				35.42%
SBC / Revenue	snapshot only																				0.00%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	225.06	2912.23	-365.77	-296.91	152.57	120.38	87.84	68.85	67.97	67.04	65.21	73.15	72.76	56.11	58.44	51.82	12.33	26.63	29.44	28.13	25.447
P/S Ratio	10.09	8.72	9.37	8.45	6.89	8.92	9.42	9.54	8.91	8.71	8.67	9.59	9.23	7.30	8.26	7.61	1.99	4.64	5.06	4.79	4.322
P/B Ratio	8.33	8.31	10.70	10.35	8.85	10.68	11.54	11.35	10.77	10.20	11.03	11.92	11.61	9.68	11.07	9.61	2.53	5.60	6.46	5.85	5.238
P/FCF	75.62	85.21	74.31	69.76	51.06	54.67	68.51	64.66	57.44	60.80	71.36	67.61	69.94	54.26	46.93	49.28	10.40	25.76	33.58	30.05	30.047
P/OCF	52.19	54.70	53.55	48.84	35.24	40.34	42.56	41.68	38.67	38.59	42.57	42.57	41.69	33.28	34.70	32.11	7.66	18.57	21.37	21.28	21.278
EV/EBITDA	44.91	46.47	58.89	55.85	39.12	46.08	39.78	34.76	31.13	30.32	30.82	34.12	32.50	27.06	29.91	26.96	7.79	14.94	16.22	15.53	15.531
EV/Revenue	10.84	9.37	9.98	9.01	7.43	9.44	10.00	10.08	9.43	9.21	9.23	10.13	9.75	7.76	8.74	8.06	2.42	5.04	5.49	5.23	5.232
EV/EBIT	127.58	346.65	-37644.53	-730.52	140.72	109.29	78.70	59.54	51.04	49.46	48.19	52.71	51.57	40.19	43.80	38.95	10.73	21.02	22.66	22.42	22.423
EV/FCF	81.28	91.55	79.15	74.38	55.06	57.84	72.66	68.32	60.80	64.26	75.95	71.41	73.88	57.64	49.65	52.22	12.60	28.03	36.46	32.83	32.832
Earnings Yield	0.4%	0.0%	-0.3%	-0.3%	0.7%	0.8%	1.1%	1.5%	1.5%	1.5%	1.5%	1.4%	1.4%	1.8%	1.7%	1.9%	8.1%	3.8%	3.4%	3.6%	3.55%
FCF Yield	1.3%	1.2%	1.3%	1.4%	2.0%	1.8%	1.5%	1.5%	1.7%	1.6%	1.4%	1.5%	1.4%	1.8%	2.1%	2.0%	9.6%	3.9%	3.0%	3.3%	3.33%
PEG Ratio	snapshot only																				1.090
EV/OCF	snapshot only																				23.250
EV/Gross Profit	snapshot only																				6.390
Acquirers Multiple	snapshot only																				22.983
Shareholder Yield	snapshot only																				1.75%
Graham Number	snapshot only																				$69.65

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	1.13	1.16	1.00	0.96	0.81	0.86	0.90	0.87	0.79	0.82	0.89	0.89	0.93	0.93	0.90	0.86	0.88	0.94	0.91	0.89	0.886
Quick Ratio	0.68	0.76	0.66	0.67	0.61	0.68	0.70	0.67	0.60	0.64	0.70	0.69	0.71	0.74	0.70	0.67	0.69	0.72	0.71	0.67	0.667
Debt/Equity	0.80	0.78	0.86	0.82	0.83	0.79	0.88	0.80	0.77	0.73	0.92	0.85	0.78	0.74	0.77	0.73	0.71	0.61	0.72	0.64	0.641
Net Debt/Equity	0.62	0.62	0.70	0.69	0.69	0.62	0.70	0.64	0.63	0.58	0.71	0.67	0.65	0.60	0.64	0.58	0.53	0.49	0.55	0.54	0.542
Debt/Assets	0.30	0.29	0.31	0.31	0.31	0.30	0.33	0.31	0.30	0.28	0.34	0.32	0.30	0.29	0.30	0.29	0.29	0.26	0.30	0.28	0.278
Debt/EBITDA	4.03	4.07	4.42	4.16	3.42	3.21	2.86	2.31	2.10	2.06	2.42	2.30	2.06	1.94	1.97	1.94	1.81	1.50	1.66	1.56	1.558
Net Debt/EBITDA	3.13	3.22	3.59	3.47	2.85	2.52	2.27	1.86	1.72	1.64	1.86	1.81	1.73	1.59	1.64	1.52	1.36	1.21	1.28	1.32	1.317
Interest Coverage	2.23	0.79	-0.01	-0.42	1.84	2.88	4.10	5.09	5.43	5.22	5.42	5.58	5.51	5.99	6.54	6.99	7.93	8.32	8.43	8.26	8.258
Equity Multiplier	2.70	2.68	2.76	2.69	2.68	2.61	2.70	2.58	2.58	2.58	2.73	2.64	2.58	2.55	2.59	2.51	2.49	2.34	2.41	2.30	2.303
Cash Ratio	snapshot only																				0.157
Debt Service Coverage	snapshot only																				11.923
Cash to Debt	snapshot only																				0.154
FCF to Debt	snapshot only																				0.304
Defensive Interval	snapshot only																				210.6 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.38	0.43	0.50	0.52	0.45	0.44	0.45	0.46	0.47	0.46	0.48	0.49	0.51	0.53	0.53	0.52	0.53	0.54	0.55	0.54	0.538
Inventory Turnover	1.31	1.91	2.37	2.71	1.81	1.81	1.71	1.73	1.71	1.63	1.67	1.64	1.79	1.91	1.82	1.73	1.67	1.80	1.78	1.66	1.661
Receivables Turnover	4.71	7.61	5.54	5.77	5.13	6.70	4.62	4.45	4.36	5.87	4.46	4.44	4.42	6.47	4.52	4.48	4.43	5.00	4.42	4.31	4.309
Payables Turnover	0.58	4.81	0.80	0.84	0.78	4.61	0.58	0.52	0.46	2.84	0.44	0.44	0.46	2.96	0.48	0.47	0.44	0.74	0.49	0.47	0.475
DSO	77	48	66	63	71	54	79	82	84	62	82	82	83	56	81	81	82	73	83	85	84.7 days
DIO	278	191	154	135	202	202	213	211	214	223	219	222	204	192	200	210	218	203	205	220	219.8 days
DPO	627	76	457	436	470	79	627	703	788	128	828	833	787	123	754	771	833	496	743	769	768.9 days
Cash Conversion Cycle	-272	163	-237	-238	-197	177	-335	-410	-490	157	-526	-529	-500	124	-473	-479	-532	-220	-455	-464	-464.5 days
Fixed Asset Turnover	snapshot only																				3.769
Operating Cycle	snapshot only																				304.5 days
Cash Velocity	snapshot only																				12.367
Capital Intensity	snapshot only																				1.885

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	26.8%	40.6%	50.4%	49.1%	37.6%	18.5%	5.7%	1.0%	-0.4%	3.3%	8.6%	10.5%	13.8%	18.0%	15.5%	15.0%	13.5%	8.6%	9.9%	8.6%	8.61%
Net Income	-41.1%	-96.5%	-1.3%	-1.3%	38.6%	28.3%	5.4%	5.9%	1.9%	81.2%	34.6%	4.5%	10.2%	18.1%	22.8%	28.8%	44.7%	45.3%	33.7%	25.9%	25.93%
EPS	-48.3%	-97.0%	-1.2%	-1.3%	33.0%	28.1%	5.4%	5.9%	1.9%	80.9%	34.6%	4.5%	10.2%	18.1%	22.7%	28.9%	4.8%	1.9%	1.7%	1.5%	1.52%
FCF	1.3%	74.6%	34.3%	20.2%	39.2%	89.1%	15.3%	23.0%	14.5%	-9.3%	-4.1%	6.2%	-3.2%	10.8%	67.3%	25.2%	65.0%	45.3%	-5.9%	12.1%	12.10%
EBITDA	-4.4%	-9.5%	-21.3%	-19.1%	8.2%	20.5%	56.7%	81.5%	58.9%	53.2%	29.4%	13.1%	12.7%	11.3%	12.7%	15.9%	17.4%	27.9%	27.4%	22.3%	22.33%
Op. Income	-33.3%	-79.5%	-99.3%	-1.1%	-16.4%	2.6%	138.2%	14.4%	2.4%	1.2%	61.4%	23.2%	14.3%	22.1%	20.6%	25.1%	39.1%	37.4%	35.5%	23.4%	23.38%
OCF Growth	snapshot only																				3.15%
Asset Growth	snapshot only																				2.91%
Equity Growth	snapshot only																				12.34%
Debt Growth	snapshot only																				-1.94%
Shares Change	snapshot only																				-49.97%
Dividend Growth	snapshot only																				97.75%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	15.2%	19.2%	22.8%	24.0%	23.2%	22.1%	20.2%	20.1%	20.3%	19.8%	20.0%	18.5%	16.0%	13.1%	9.8%	8.7%	8.8%	9.8%	11.3%	11.3%	11.32%
Revenue 5Y	6.6%	10.2%	13.2%	15.2%	15.2%	14.6%	14.5%	14.8%	16.0%	15.7%	16.3%	16.3%	16.2%	17.3%	16.8%	17.1%	17.6%	17.2%	17.0%	15.8%	15.75%
EPS 3Y	-19.9%	-65.1%	—	—	-5.8%	27.5%	37.5%	34.2%	25.7%	16.2%	10.4%	13.0%	61.8%	3.0%	—	—	1.6%	83.8%	64.0%	50.2%	50.23%
EPS 5Y	-12.8%	-51.7%	—	—	-14.1%	-2.3%	6.4%	13.3%	14.6%	17.5%	16.4%	19.9%	21.6%	34.7%	33.8%	26.6%	66.1%	40.0%	34.6%	36.2%	36.16%
Net Income 3Y	-15.3%	-62.7%	—	—	-0.3%	35.0%	45.7%	42.1%	33.2%	23.1%	16.8%	19.5%	64.1%	3.0%	—	—	66.4%	46.0%	30.2%	19.2%	19.24%
Net Income 5Y	-9.8%	-49.8%	—	—	-10.5%	1.8%	10.9%	18.1%	19.5%	22.5%	21.3%	24.1%	25.9%	39.4%	38.6%	31.0%	30.4%	26.2%	21.2%	22.6%	22.60%
EBITDA 3Y	9.0%	2.0%	-2.1%	-0.7%	6.1%	10.6%	16.2%	18.3%	18.0%	18.6%	16.8%	18.4%	24.7%	27.1%	31.7%	33.5%	28.1%	29.7%	22.9%	17.0%	17.04%
EBITDA 5Y	6.0%	0.7%	-0.6%	-2.1%	1.2%	6.5%	11.2%	15.1%	17.4%	14.4%	13.7%	15.0%	16.4%	18.2%	18.0%	16.8%	16.8%	18.9%	18.0%	18.7%	18.68%
Gross Profit 3Y	11.5%	13.3%	16.2%	17.2%	17.9%	18.0%	18.2%	19.1%	20.4%	20.8%	21.4%	21.3%	20.8%	20.6%	17.8%	16.4%	15.6%	14.6%	14.3%	13.1%	13.09%
Gross Profit 5Y	3.7%	5.8%	8.4%	10.3%	11.5%	12.0%	13.3%	14.4%	16.4%	17.0%	17.4%	17.4%	16.9%	17.6%	17.4%	17.5%	18.2%	17.7%	17.7%	17.4%	17.35%
Op. Income 3Y	-1.8%	-32.2%	-78.2%	—	-11.5%	8.7%	21.2%	24.1%	23.7%	16.6%	14.5%	16.8%	48.1%	1.1%	5.5%	—	75.5%	54.1%	38.2%	23.9%	23.91%
Op. Income 5Y	-3.9%	-26.4%	-61.8%	—	-15.6%	0.4%	9.4%	17.4%	21.9%	19.3%	18.3%	20.8%	21.9%	27.9%	28.2%	24.2%	24.7%	21.6%	19.7%	19.7%	19.72%
FCF 3Y	—	45.3%	1.1%	90.5%	65.9%	1.4%	62.0%	60.8%	53.4%	44.1%	14.1%	16.2%	15.6%	23.9%	22.8%	17.8%	22.3%	13.5%	14.7%	14.2%	14.23%
FCF 5Y	51.5%	15.9%	51.9%	30.9%	16.6%	29.9%	27.6%	33.1%	—	39.4%	58.7%	55.3%	38.3%	70.2%	46.8%	40.8%	42.0%	37.0%	18.5%	17.1%	17.13%
OCF 3Y	65.8%	31.6%	45.2%	33.7%	32.2%	48.9%	40.6%	40.7%	33.3%	29.2%	13.7%	19.7%	21.3%	25.8%	21.7%	20.7%	19.7%	14.3%	13.8%	10.7%	10.70%
OCF 5Y	18.1%	7.5%	19.0%	19.6%	14.2%	22.3%	23.7%	26.3%	49.4%	31.6%	32.5%	28.3%	24.3%	31.9%	30.2%	29.6%	28.2%	25.0%	16.8%	16.5%	16.46%
Assets 3Y	20.4%	20.2%	18.0%	16.0%	16.9%	16.3%	19.1%	17.2%	14.4%	14.9%	16.4%	12.3%	-0.7%	-0.4%	1.9%	5.2%	6.7%	5.7%	5.6%	6.2%	6.22%
Assets 5Y	11.1%	11.0%	10.5%	8.2%	7.8%	8.8%	8.8%	9.5%	9.4%	10.8%	10.9%	11.0%	12.2%	11.1%	13.2%	13.4%	12.3%	11.3%	11.9%	9.5%	9.46%
Equity 3Y	49.3%	46.6%	51.3%	38.4%	42.4%	41.3%	49.2%	45.1%	45.0%	35.8%	37.4%	36.1%	0.8%	1.3%	4.1%	7.6%	9.3%	9.5%	9.8%	10.3%	10.34%
Book Value 3Y	41.3%	37.1%	41.2%	30.7%	34.5%	33.4%	40.9%	37.0%	36.9%	28.2%	29.9%	28.7%	-0.6%	0.9%	4.1%	7.6%	73.4%	37.9%	38.3%	39.0%	39.02%
Dividend 3Y	-2.9%	-4.0%	-1.0%	0.2%	-1.6%	-1.6%	-5.0%	-4.8%	-4.8%	-4.8%	-5.2%	-5.5%	-0.3%	0.8%	3.4%	3.4%	62.4%	28.7%	25.5%	25.5%	25.54%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.53	0.60	0.64	0.70	0.75	0.81	0.83	0.84	0.90	0.93	0.92	0.92	0.94	0.98	0.96	0.94	0.94	0.97	0.99	0.99	0.994
Earnings Stability	0.45	0.50	0.34	0.41	0.59	0.01	0.00	0.04	0.30	0.34	0.24	0.27	0.65	0.65	0.54	0.51	0.83	0.79	0.68	0.68	0.676
Margin Stability	0.95	0.92	0.92	0.92	0.93	0.92	0.92	0.93	0.93	0.92	0.92	0.92	0.93	0.91	0.91	0.92	0.93	0.95	0.97	0.97	0.968
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	1.00	1.00	1.00	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.84	0.50	0.20	0.20	0.85	0.50	0.20	0.20	0.50	0.50	0.50	0.50	0.96	0.93	0.91	0.88	0.82	0.82	0.87	0.90	0.896
Earnings Smoothness	0.48	0.00	—	—	0.68	0.00	—	—	0.03	0.42	0.71	0.96	0.90	0.83	0.80	0.75	0.63	0.63	0.71	0.77	0.770
ROE Trend	-0.15	-0.15	-0.24	-0.24	-0.06	-0.01	0.01	0.06	0.11	0.11	0.12	0.10	0.05	0.05	0.04	0.02	0.05	0.05	0.04	0.03	0.034
Gross Margin Trend	-0.08	-0.13	-0.13	-0.12	-0.07	-0.01	0.03	0.07	0.10	0.13	0.11	0.10	0.06	0.04	0.03	0.01	0.02	0.00	-0.00	0.00	0.001
FCF Margin Trend	0.07	0.05	0.03	0.02	0.03	0.07	0.00	0.01	0.02	0.01	-0.01	0.01	-0.01	-0.02	0.05	0.01	0.05	0.04	0.00	0.01	0.011
Sustainable Growth Rate	-9.2%	-13.6%	—	—	-6.2%	-2.8%	0.7%	4.6%	3.9%	3.9%	5.1%	5.1%	4.8%	6.0%	7.2%	8.0%	10.2%	11.8%	12.5%	11.7%	11.72%
Internal Growth Rate	—	—	—	—	—	—	0.3%	1.8%	1.5%	1.5%	1.9%	2.0%	1.9%	2.4%	2.8%	3.2%	4.2%	5.1%	5.3%	5.1%	5.13%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	4.31	53.24	-6.83	-6.08	4.33	2.98	2.06	1.65	1.76	1.74	1.53	1.72	1.75	1.69	1.68	1.61	1.61	1.43	1.38	1.32	1.322
FCF/OCF	0.69	0.64	0.72	0.70	0.69	0.74	0.62	0.64	0.67	0.63	0.60	0.63	0.60	0.61	0.74	0.65	0.74	0.72	0.64	0.71	0.708
FCF/Net Income	snapshot only																				0.936
OCF/EBITDA	snapshot only																				0.668
CapEx/Revenue	6.0%	5.7%	4.9%	5.2%	6.1%	5.8%	8.4%	8.1%	7.5%	8.2%	8.2%	8.3%	8.9%	8.5%	6.2%	8.3%	6.9%	7.0%	8.6%	6.6%	6.57%
CapEx/Depreciation	snapshot only																				0.634
Accruals Ratio	-0.06	-0.07	-0.10	-0.10	-0.07	-0.06	-0.05	-0.04	-0.05	-0.04	-0.03	-0.05	-0.05	-0.05	-0.05	-0.05	-0.05	-0.04	-0.04	-0.03	-0.029
Sloan Accruals	snapshot only																				-0.047
Cash Flow Adequacy	snapshot only																				1.549
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	1.2%	1.2%	1.1%	1.2%	1.4%	1.1%	1.1%	1.1%	1.1%	1.1%	1.1%	0.9%	1.0%	1.2%	1.1%	1.1%	4.3%	1.8%	1.6%	1.7%	1.86%
Dividend/Share	$1.29	$1.25	$1.40	$1.40	$1.40	$1.40	$1.42	$1.43	$1.44	$1.44	$1.43	$1.43	$1.48	$1.48	$1.58	$1.58	$6.36	$3.17	$3.13	$3.13	$3.18
Payout Ratio	2.6%	34.4%	—	—	2.1%	1.3%	94.4%	72.4%	76.0%	75.2%	70.6%	69.3%	71.3%	65.8%	63.6%	59.5%	52.8%	48.4%	47.0%	46.8%	46.75%
FCF Payout Ratio	88.1%	1.0%	83.3%	81.7%	71.6%	60.3%	73.6%	68.0%	64.2%	68.2%	77.2%	64.0%	68.5%	63.6%	51.1%	56.6%	44.5%	46.8%	53.7%	49.9%	49.93%
Total Payout Ratio	2.6%	34.4%	—	—	2.1%	1.3%	94.4%	72.4%	76.0%	75.2%	70.6%	69.3%	71.3%	65.8%	63.6%	59.5%	52.9%	50.5%	49.1%	49.2%	49.22%
Div. Increase Streak	0	0	1	1	1	1	1	1	1	1	1	0	1	1	1	0	1	1	0	0	0
Chowder Number	0.09	0.09	0.21	0.21	0.15	0.14	0.03	0.03	0.04	0.04	0.02	0.01	0.04	0.04	0.12	0.12	0.12	0.09	0.00	0.01	0.006
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.1%	0.09%
Net Buyback Yield	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.0%	-0.1%	-0.1%	-0.4%	-0.1%	-0.1%	-0.1%	-0.11%
Total Shareholder Return	1.2%	1.2%	1.1%	1.2%	1.4%	1.1%	1.1%	1.0%	1.1%	1.1%	1.1%	0.9%	1.0%	1.2%	1.0%	1.0%	3.9%	1.7%	1.5%	1.6%	1.56%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.96	-0.42	0.81	0.68	1.88	1.31	1.12	1.02	0.87	0.86	0.85	0.83	0.82	0.81	0.84	0.83	0.82	0.82	0.80	0.83	0.830
Interest Burden (EBT/EBIT)	0.55	-0.26	120.00	3.38	0.46	0.65	0.76	0.80	0.82	0.81	0.82	0.82	0.82	0.83	0.85	0.86	0.87	0.88	0.88	0.88	0.879
EBIT Margin	0.08	0.03	-0.00	-0.01	0.05	0.09	0.13	0.17	0.18	0.19	0.19	0.19	0.19	0.19	0.20	0.21	0.23	0.24	0.24	0.23	0.233
Asset Turnover	0.38	0.43	0.50	0.52	0.45	0.44	0.45	0.46	0.47	0.46	0.48	0.49	0.51	0.53	0.53	0.52	0.53	0.54	0.55	0.54	0.538
Equity Multiplier	3.30	3.14	3.25	3.30	2.69	2.65	2.73	2.63	2.63	2.59	2.72	2.61	2.58	2.57	2.66	2.57	2.53	2.44	2.49	2.40	2.402

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$0.49	$0.04	$-0.34	$-0.40	$0.65	$1.05	$1.51	$1.98	$1.89	$1.91	$2.03	$2.06	$2.08	$2.25	$2.49	$2.66	$12.04	$6.55	$6.66	$6.70	$6.70
Book Value/Share	$13.28	$12.69	$11.64	$11.52	$11.27	$11.88	$11.47	$11.98	$11.92	$12.54	$12.00	$12.66	$13.05	$13.06	$13.15	$14.34	$58.79	$31.16	$30.32	$32.20	$32.64
Tangible Book/Share	$-8.17	$-7.47	$-7.97	$-7.62	$-7.75	$-7.08	$-7.53	$-6.70	$-6.55	$-6.08	$-6.85	$-6.72	$-6.35	$-5.57	$-5.65	$-4.63	$-17.32	$-6.67	$-6.90	$-5.51	$-5.51
Revenue/Share	$10.97	$12.09	$13.29	$14.11	$14.48	$14.22	$14.05	$14.26	$14.42	$14.67	$15.26	$15.75	$16.41	$17.31	$17.61	$18.12	$74.47	$37.60	$38.72	$39.34	$39.51
FCF/Share	$1.46	$1.24	$1.68	$1.71	$1.95	$2.32	$1.93	$2.10	$2.24	$2.10	$1.85	$2.23	$2.17	$2.33	$3.10	$2.80	$14.28	$6.77	$5.84	$6.27	$5.44
OCF/Share	$2.12	$1.93	$2.33	$2.44	$2.83	$3.15	$3.11	$3.26	$3.32	$3.31	$3.11	$3.55	$3.63	$3.80	$4.19	$4.29	$19.40	$9.39	$9.17	$8.85	$8.86
Cash/Share	$2.39	$2.07	$1.87	$1.57	$1.57	$2.00	$2.07	$1.86	$1.64	$1.88	$2.57	$2.27	$1.58	$1.77	$1.73	$2.28	$10.48	$3.68	$4.92	$3.18	$3.22
EBITDA/Share	$2.65	$2.44	$2.25	$2.28	$2.75	$2.91	$3.53	$4.13	$4.37	$4.46	$4.57	$4.67	$4.92	$4.96	$5.15	$5.42	$23.10	$12.69	$13.11	$13.25	$13.25
Debt/Share	$10.67	$9.92	$9.96	$9.46	$9.40	$9.35	$10.10	$9.56	$9.16	$9.17	$11.07	$10.75	$10.12	$9.64	$10.16	$10.53	$41.85	$19.02	$21.73	$20.64	$20.64
Net Debt/Share	$8.28	$7.85	$8.10	$7.90	$7.83	$7.34	$8.03	$7.70	$7.52	$7.29	$8.50	$8.48	$8.54	$7.87	$8.43	$8.25	$31.36	$15.34	$16.81	$17.46	$17.46

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	3.750
Altman Z-Prime	snapshot only																				5.702
Piotroski F-Score	5	6	4	4	6	6	7	7	6	7	7	8	7	7	8	7	8	8	8	9	9
Beneish M-Score	-1.94	-1.94	-2.26	-2.37	-2.80	-2.80	-2.62	-2.54	-2.59	-2.73	-2.54	-2.64	-2.56	-2.38	-2.53	-2.42	-2.54	-2.32	-2.56	-2.52	-2.519
Ohlson O-Score	snapshot only																				-8.811
Net-Net WC	snapshot only																				$-24.01
EVA	snapshot only																				$3855736884.03

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA-
Credit Score	56.70	49.20	51.35	51.95	58.85	64.35	68.70	73.35	72.00	73.35	72.45	73.35	73.35	74.85	82.50	75.45	70.00	82.00	74.95	82.00	82.000
Credit Grade	snapshot only																				4
Credit Trend	snapshot only																				6.550
Implied Spread (bps)	snapshot only																				100.000

AZN NYSE

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet